Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections.
- DOI
- 10.1007/s43441-024-00647-0
- Published
- 2024 Jul
- Container
- Therapeutic innovation & regulatory science
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-024-00647-0,
title = {Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections.},
author = {Alhomaidan AM and Al-Murikhi NG and Al-Qarni MA and Al Fahaadi FA and Al Otaibi KS and Hafiz R and Almadani OA and Al Rafie TA and Al Ageel MA and Dahhas MA},
year = {2024},
journal = {Therapeutic innovation \& regulatory science},
doi = {10.1007/s43441-024-00647-0},
url = {https://doi.org/10.1007/s43441-024-00647-0}
}RIS
TY - JOUR TI - Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections. AU - Alhomaidan AM AU - Al-Murikhi NG AU - Al-Qarni MA AU - Al Fahaadi FA AU - Al Otaibi KS AU - Hafiz R AU - Almadani OA AU - Al Rafie TA AU - Al Ageel MA AU - Dahhas MA PY - 2024 JO - Therapeutic innovation & regulatory science DO - 10.1007/s43441-024-00647-0 UR - https://doi.org/10.1007/s43441-024-00647-0 ER -
APA
AM, A., NG, A., MA, A., FA, A. F., KS, A. O., R, H., OA, A., TA, A. R., MA, A. A., & MA, D. (2024). Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-024-00647-0
Source records
- pubmed · retrieved 2026-09-26T07:39:38.003Z